Bridgeway Capital Management’s Voyager Therapeutics VYGR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $350K | Sell |
112,459
-48,200
| -30% | -$150K | 0.01% | 835 |
|
|
2025
Q1 | $543K | Buy |
160,659
+110,553
| +221% | +$374K | 0.01% | 733 |
|
|
2024
Q4 | $284K | Sell |
50,106
-135,003
| -73% | -$765K | 0.01% | 934 |
|
|
2024
Q3 | $1.08M | Buy |
185,109
+2,278
| +1% | +$13.3K | 0.02% | 663 |
|
|
2024
Q2 | $1.45M | Buy |
182,831
+3,060
| +2% | +$24.2K | 0.03% | 590 |
|
|
2024
Q1 | $1.67M | Sell |
179,771
-1,025
| -0.6% | -$9.54K | 0.03% | 623 |
|
|
2023
Q4 | $1.53M | Buy |
+180,796
| New | +$1.53M | 0.03% | 661 |
|
|
2023
Q2 | – | Sell |
-101,781
| Closed | -$785K | – | 1452 |
|
|
2023
Q1 | $785K | Hold |
101,781
| – | – | 0.02% | 780 |
|
|
2022
Q4 | $621K | Hold |
101,781
| – | – | 0.02% | 844 |
|
|
2022
Q3 | $603K | Buy |
101,781
+15,000
| +17% | +$88.9K | 0.02% | 850 |
|
|
2022
Q2 | $513K | Hold |
86,781
| – | – | 0.01% | 870 |
|
|
2022
Q1 | $661K | Buy |
86,781
+50,000
| +136% | +$381K | 0.01% | 873 |
|
|
2021
Q4 | $100K | Sell |
36,781
-145,100
| -80% | -$394K | ﹤0.01% | 1222 |
|
|
2021
Q3 | $478K | Buy |
181,881
+25,581
| +16% | +$67.2K | 0.01% | 1045 |
|
|
2021
Q2 | $646K | Sell |
156,300
-108,039
| -41% | -$447K | 0.01% | 994 |
|
|
2021
Q1 | $1.25M | Buy |
+264,339
| New | +$1.25M | 0.02% | 792 |
|
|
2018
Q4 | – | Sell |
-35,000
| Closed | -$662K | – | 1464 |
|
|
2018
Q3 | $662K | Sell |
35,000
-35,000
| -50% | -$662K | 0.01% | 1062 |
|
|
2018
Q2 | $1.37M | Hold |
70,000
| – | – | 0.01% | 754 |
|
|
2018
Q1 | $1.32M | Hold |
70,000
| – | – | 0.01% | 741 |
|
|
2017
Q4 | $1.16M | Hold |
70,000
| – | – | 0.01% | 790 |
|
|
2017
Q3 | $1.44M | Buy |
+70,000
| New | +$1.44M | 0.02% | 705 |
|